Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prenatal Screening and Selective Reduction in Twin Pregnancies
NCT02982356Unknown
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Open-label trial of potassium chloride in chromosomal abnormality and congenital structural anomaly, sponsored by Shanghai First Maternal and Infant Health Hospital. Primary endpoint: Success rate for the operation at 1 week. Status: unknown.
02
Drugs
potassium chloride
03
Conditions
chromosomal abnormalitycongenital structural anomaly
Beyond the preview
Go deeper on NCT02982356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02982356.